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Abstract 
Using ultrasonic irradiations, three new complexes of type [ZnL2].CH3CN, [NiLCl] and [CoL2] 
(where L is 2-acetylpyridine -4N-p-chlorophenylthiosemicarbazone ligand) have been prepared 
and investigated using various spectroscopic methods. Crystal structures of ZnL2 and NiLCl 
complexes displayed distorted octahedral and square-planar coordination geometry around the 
central metal, respectively. The UV–Visible and mass spectroscopic analysis revealed 1:2 
(metal:ligand) stoichiometry for Co(II) complex. The synthesized complexes have been used as 
precursors for preparing their corresponding nano-sized metal oxides via thermal decomposition. 
The nanostructures of metal oxides were characterized by scanning electron microscope (SEM), 
energy dispersive X‒ray (EDX), X–ray diffraction (XRD) and Fourier transform infrared (FT–
IR). The in vitro antibacterial activity of thiosemicarbazone complexes and their corresponding 
nano-sized metal oxides were studied against a series of gram positive and gram negative 
bacteria, using the zone inhibition methods. While NiLCl complex was shown to possess more 
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antimicrobial activity than its nano-sized metal oxide, the prepared nano-sized zinc and cobalt 
oxides have shown the highest activity.  
Keywords: Sonochemical synthesis; Thiosemicarbazone; Transition metal complexes; nano-
sized metal oxide; Antibacterial. 
 
1. Introduction 
By combination of hydrazine group with aldehydes or ketones, one of the important classes of 
Schiff base ligands, namely thiosemicarbazones were generated and have found to possess 
various biological and pharmaceutical activities. Pyridine-2-carbaldehyde thiosemicarbazone 
was the first reported heterocyclic compound with carcinostatic properties [1]. Further 
investigations revealed that thiosemicarbazones possessing N-heterocycles such as pyridine in 
their structures usually show significant biological activities in vitro and in vivo [2]. 
Interestingly, the study of the structure‒activity relationship of thiosemicarbazone derivatives 
have shown that their biological activity can be affected by introducing structural variation in N-
heterocyclic ring and terminal amino substitution [3]. Due to high delocalized π-electrons 
throughout the moiety, thiosemicarbazones usually form a planar structure and also show good 
versatility as ligands [4]. The deprotonated thiosemicarbazone ligands represented by two 
tautomeric keto-enol forms and usually coordinate to metal ions through sulfur (S) and 
hydrazinic N donor atoms which are believed to possess the pharmaceutical activity of the 
original molecule [5]. The other potential donor atoms on the thiosemicarbazone backbone can 
further increase the coordination possibilities of these chelating ligands.  
Moreover, the metal chelation ability of thiosemicarbazone ligands can cause drastic changes in 




of thiosemicarbazones usually show a higher bioactivity and lower side effects compared to the 
free ligands [7, 8]. Previous studies have illustrated that the lipophilicity, which controls the rate 
of entry of molecules into the cell, may be enhanced by complexation [9]. However, the 
mechanisms involved in the pharmaceutical activity of thiosemicarbazones and their complexes 
are far from clear [10] and the direct relationship between the complexation and therapeutic 
strategy are still intriguing and controversial.  
In recent years, the growth of drug-resistance pathogens due to the biological and morphological 
modifications has led the great demand of novel drugs with enhanced, targeted activity [11]. 
Further to this, metallo-drugs can act as effective antimicrobial and antibacterial agents in the 
mechanisms differing from organic drugs [12]. In this context, the synthesis of different 
thiosemicarbazone ligands and their complexes particularly with the first row of transition metals 
have received considerable attention due to the wide range of applications in pharmacological 
fields of both ligand and complexes [13, 14]. 
Metal oxide nanoparticles have been widely studied for their potent antibacterial activities [15]. 
Previous results have shown that metal oxide nanoparticles exhibit bactericidal properties 
through reactive oxygen species (ROS) generation effected by their physical structure and metal 
ion release [16]. Between different methodologies used for preparation of metal oxide 
nanomaterials, such as sol-gel, solid-state synthesis, and microemulsion methods, [17, 18], 
thermal decomposition process has been attracted much attention [19-21]. This technique 
involves the heat decomposition of the coordination or organometallic compounds, as precursors, 
to form the nano-crystalline products [22]. The thermal decomposition technique has its 
advantages; it is easy to be carried out under normal atmosphere, does not involved complicated 




state reactions (long reaction time), sol-gel (difficult to control), and also it offers high purity and 
yield of the products. Therefore, the thermal decomposition technique has been explored as a 
convenient and efficient pathway for the preparation of nano-scale metal oxides [23, 24]. 
Keeping in mind the above observations and in continuation of our work in the area of 
thiosemicarbazone complexes [25, 26] we recently reported the antibacterial and antioxidant 
study of bioactive 2-acetylpyridine-4N-p-chlorophenylthiosemicarbazone ligand and the 
corresponding copper (II) complex [Cu(L)Cl]. Results have shown that the involvement of 
pyridine cycle in the ligand backbone enhanced the antibacterial activity of the 
thiosemicarbazone ligand in comparison with its thiosemicarbazide precursor. Moreover, we 
have established that copper complex [CuLCl] has more antibacterial activity than the ligand 
alone, in most cases [27]. These results encouraged us to further investigate the antibacterial 
properties of other transition metal complexes of this thiosemicarbazone ligand. Therefore, here 
we describe the synthesis of three new Zn(II), Ni(II) and Co(II) complexes with 2-
acetylpyridine-4N-p-chlorophenylthiosemicarbazone ligand using ultrasonic irradiations, which 
significantly reduced the synthetic time and temperature. The analytical and physico-chemical 
analysis confirmed the composition and the structure of the newly synthesized complexes. 
Moreover, the corresponding nano-sized metal oxide derivatives were prepared by thermal 
decomposition method and their nanostructures were characterized by different spectroscopic 
methods. In addition, the in vitro antibacterial activity of thiosemicarbazone complexes and their 
metal oxides have been screened against a series of gram positive and gram negative bacteria, 
using the zone inhibition methods. Investigation of various organometallic and nanostructure 




the effect of metal cations and complex structure on their mechanism and thereby encouraging 
further research in designing promising novel compounds with drug-like properties. 
 
2. Experimental 
2.1. Chemical reagents, Instrumentation and physical measurements 
The chemicals for the synthesis were commercial products of the highest available purity and 
were used without further purification. 2-acetylpyridine-4N-p-chlorophenylthiosemicarbazone 
ligand has been synthesized as described previously [27]. Infrared spectra (4000–400 cm
-1
) of 
solid samples were taken as 1% dispersion in KBr pellets using a Shimadzu IR-470 FT-IR 
spectrophotometer. Elemental analysis (C, H, N) data were performed on a Perkin Elmer 2400 
CHNS/O elemental analyzer. NMR spectra were obtained on a Bruker 500-DRX Avance 
spectrometer in DMSO-d6. Electron ionization mass spectrometric (EI-MS) measurements were 
carried out with an Agilent HP 5973 spectrometer. UV–vis spectra were recorded by a Photonix 
Ar2017 UV–vis spectrophotometer. The scanning electron microscopy (SEM) images were 
taken on a KYKY‒EM3200 scanning electron microscope. Powder X-ray diffraction (PXRD) 
data were collected with a Philips pw 1830 diffractometer (Cu-Kα X-radiation, λ = 1.54 Å). The 
elemental analysis was recorded with an energy dispersive X-ray (EDX) analyzer, MIRA3 
FEG‒SEM series.  
 
2.2. Sonochemical Synthesis of Zn(II), Co(II) and Ni(II) thiosemicarbazone complexes 
A solution of the ligand HL (0.100 g, 1mmol), which was dissolved in 5 mL of ethanol was 
added drop wise to a solution of different metal salt (Zn(NO3)2.6H2O (0.076 g, 1mmol), 




it was positioned in a large-density ultrasonic probe, operating at 37 kHz with a maximum force 
output of 320 W. The reaction mixture was then sonicated for 30 min. The products was filtered 
off, washed with cold ethanol and diethyl ether and dried in air. The crystals of Zn and Ni 
complex were obtained by slow diffusion of acetonitrile in DMF solution of the compound.  
Anal. Calc for ZnL2.CH3CN (C30H27Cl2N9S2Zn): C, 50.46; H, 3.81; N, 17.66;. Found: C, 51.03; 
H, 3.16; N, 17.15. 
Anal. Calc for [CoL2] (C28H24Cl2N8S2Co): C, 50.46; H, 3.63; N, 16.81;. Found: C, 50.82; H, 
4.07; N, 16.68. 
Anal. Calc for NiLCl (C14H12Cl2N4SNi): C, 42.26; H, 3.04; N, 14.08;. Found: C, 43.16; H, 3.24; 
N, 14.10. 
2.3. Synthesis of metal oxide nanoparticles from their corresponding complexes 
50 mg of the different metal complexes were ground, placed in a ceramic crucible and calcined 
in the presence of air at 500ºC with a heating rate of 10 °C min
‒1
 for 4 h to remove the organic 
contents. The samples were allowed to cool slowly to room temperature. The resulting nano-
sized metal oxides were washed with ethanol and dried in air.  
 
2.4. Crystal structure determination and refinement 
Yellow block shaped crystals of Zn complexes and red needle shaped crystals of Ni complexes 
were obtained by slow diffusion of acetonitrile in DMF solution. A room temperature single-X-
ray data collection was carried out on a Bruker Kappa Apex II, with Charge Coupled Device 
detector utilizing Mo-K radiation. The data were collected by scanning  and  in different 
regions, with exposure times of 60 seconds per frame. The data were corrected for Lorentz and 




empirically using SADABS, since the crystal faces could not be determined reliably for 
numerical absorption corrections. The structure solutions were obtained by direct method and 
refined using the least square method incorporated into the SHELXTL package. All the non-
hydrogen atoms were refined anisotropically and all the hydrogen atoms were refined in the 
idealized geometrically positions using a rigid model with C‒H=0.93 Å, N‒H=0.86 Å and 
isotropic displacement parameters Uiso(H)= 1.2Ueq (C) for the aromatic ring and Uiso(H) = 1.5Ueq 
(C) for the CH3 group. A summary of crystal data, experimental details, and refinement results 
are given in Table 1. 
< Table 1. > 
2.5. Antibacterial assay 
Antibacterial activity of Zn(II), Co(II) and Ni(II) thiosemicarbazone complexes and their 
corresponding metal oxide nanoparticles were tested in vitro using agar well diffusion method 
[28] against Micrococcus luteus (ATCC 4698), Staphylococcus aureus (ATCC 29213), Basillud 
subtilis (DSM 6887), Escherichia coli (ATCC 25922) and Pseudomonas aeruginosa (ATCC 
27853), supplied from the Iranian biological resource center, Tehran, Iran. The nutrient agar and 
nutrient broth cultures were prepared according to manufactures instructions and were incubated 
at 37°C. The nutrient agar plates were seeded with a suspension of 30μL of each bacterium after 
incubation for the appropriate time. Cups (0.5 cm in diameter) were cut in the agar using a 
sterilized glass tube. Then 30 μL of the test agents at a concentration of 1000 μg/ml in DMSO 
were introduced into each well. The plates were incubated at 37°C for 24 hrs. Clear zones around 
the wells showed the positive results and cloudiness indicates that bacterial growth has not been 
inhibited by the concentration of compound present in the medium. The diameter of inhibition 




DMSO in the medium did not affect the growth of any of the microorganisms tested. All 
experiments were made in triplicate to assess their reproducibility and the results were confirmed 
in three independent experiments. The results are reported as mean ± standard deviation of zone 
of inhibition in millimeter. Antibacterial activity of each compound was compared with 
penicillin G and tetracycline as standard drugs. DMSO was used as a negative control.  
 
3. Results and discussion 
3.1. General aspects 
The thiosemicarbazone metal complexes were obtained by the reaction of corresponding metal 
salts and thiosemicarbazone ligand, in ethanolic solution. Experimental results showed that the 
thiosemicarbazone behaves as monoanionic ligand with deprotonation of hydrazine (N
2
H) 
proton. The infrared spectra of the thiosemicarbazone ligand and its metal complexes are shown 
in Fig. 1. A sharp and intense peak at 1584 cm
−1





). This band is shifted to lower frequencies in the spectra of the complexes (Table 2) 
which indicates the coordination of nitrogen to metal center [29]. Additionally, the bands at the 
3231 cm
-1
 and 838 cm
-1
 in the IR spectrum of the free ligand, are corresponding to the ν(N
2
H) 
and ν(C=S), respectively. The attributed bands for N
2
H and C=S vanished upon coordinating to 
the M
2+
 center (Table 2) suggesting the involvement of N
2
 and sulfur in coordination [30]. The 
new band at around 1600 cm
-1





. The metal ions are also bound by pyridine groups as evidenced by slightly 
shifting of the in-plane pyridine deformation bands to higher wavenumbers of complexes [31]. 
< Table 2. > 




Fig. 2 shows the 
1
H NMR spectra of Zn(II) and Ni(II) complexes which were recorded in 
DMSO‒d6 solvent. The proton resonance for methyl group is found at δ=3.32 and 2.70 ppm for 
Ni(II) and Zn(II) complexes, respectively. The remarkable shift for CH3 moiety in complexes 
compared to HL ligand [27] suggests the involvement of the azomethine nitrogen in coordination 
to metal ions. Peaks of the aromatic protons of the p-chlorophenyl and pyridine groups were 
found in the region 7.33‒8.26 ppm and 7.31-7.95 for Ni (II) and Zn(II) complexes, respectively. 
The signal arising from N(3)H moiety of HL at δ=8.85 [27] was not observed in 
1
H NMR spectra 
of the complexes. This observation proves that the ligand has undergone deprotonation before 
coordinating to metal center. The signals corresponding to N(1)H are observed at δ=10.02 and 
9.42 ppm for Ni (II) and Zn(II) complexes, respectively. In addition, detection of only one set of 
signals in the 
1
H NMR spectrum of ZnL2 complex means that equivalent nuclei in the complexed 
ligand moieties are magnetically equivalent showing the same chemical shift. Residual solvent 
peaks for ethanol were seen at δ=7.26 and 2.50 ppm in 
1
H NMR spectrum of ZnL2 complex. 
<Fig. 2> 
The electronic spectral data for prepared thiosemicarbazone complexes in DMSO showed similar 
profiles which indicate the same mode of coordination of the thiosemicarbazone in complexes 
(Fig. 3). The high energy transitions were observed below 250 nm originate from π−π* 
transitions associated with the aromatic rings in the ligands [32]. The bands recorded at the 
region 250-350 nm observed in the spectra of the ligand generally cab be assigned to intra-ligand 
n→π* and π→π* transitions [33]. The synthesized metal complexes showed a characteristic 
absorption bands in the region 320‒450 nm which is due to the charge transfer transition from 
HOMO of sulfur (Pπ-orbital) to the LUMO of metal (dπ-orbital) [34].  





3.2. Description of the molecular structures of [ZnL2].CH3CN and [NiLCl] complexes 
3.2.1. Structure of [ZnL2].CH3CN complex 
[ZnL2].CH3CN crystallizes in the space group C2/c, with one Zn-atom and solvent molecule at 
special Wyckoff position 4e and the ligands at the general position 8f. The crystal structure 
consists of four crystallographically similar Zn(II) species in the asymmetric unit with a distorted 
octahedral geometry. Zn(II) ions are coordinated to two thiosemicarbazone ligands in their 
deprotonated form via the NNS donor atoms in a meridional fashion (Fig. 4). Selected bond 
lengths and angles with their standard deviations for [ZnL2].CH3CN complex are given in Table 
3. The Zn‒S and Zn‒N(4) bond distances are 2.4632(8) Å and 2.244(2) Å, respectively and 
similar to those found in previous studies [35]. The Zn-N bond to the imine N-atom (2.147(2) Å) 
is shorter and of course stronger than that of pyridyl ring (2.244(2) Å) (Table 3). Given the fact 
that N(2) was deprotonated, the C‒S bond is formally a single bond (1.725(3) Å) and the 
adjacent C(7)‒N(2) bond (1.314(4) Å) was consistent with a tautomeric enol form. The bond 
lengths and angles for thiosemicarbazone coordination sites observed for [ZnL2].CH3CN are 
similar to previously reported 1:2 Zn(II)-thiosemicarbazone complexes in which the both ligands 
are deprotonated at the thioamide N-atom (N(2) in this structure) [2]. The molecules of 
[ZnL2].CH3CN complex are connected to each other by weaker hydrogen bonds N–H⋯S of 
2.698 Å (Fig. 5).  
< Table 3. > 
< Fig. 4. > 
<Fig.5> 
 




[NiLCl] crystallizes in the space group C2/m, with all atoms at special Wyckoff position 4i 
except the H14B at the general position 8j. The asymmetric unit cell of the structure of [NiLCl] 
consists of four crystallographically dependent Ni(II) species. In this compound Ni(II) ion has 
four-coordination number in distorted square planar geometry, where the tridentate 
thiosemicarbazone ligand is deprotonated at N(2) atom. An ORTEP drawing of the asymmetric 
unit of [NiLCl] is presented in Fig. 6. Selected bond lengths and angles with their standard 
deviations for [NiLCl] are listed in Table 4. A notable feature is that the Ni-N(3) bond to the 
imine N-atom (1.857(3) Å) is much shorter than the bond to the pyridyl N-donor (1.920(3) Å) 
similar to that observed in  [ZnL2].CH3CN complex. This lengthening of the Ni-N bond can be 
due to the trans influence of the Ni-Cl(2) bond. The Ni‒S distance is 2.1548 Å which is a little 
shorter than those observed for [ZnL2].CH3CN but is within the range of those already reported 
in related Ni(II) complexes [36, 37]. In addition, the π–π stacking between the (Cg(i) → Cg(j) 
interactions which form a 3D network  have been presented in Fig. 7 and Table 5. 
< Table 4.> 
<Fig.6> 
<Fig.7> 
< Table 5.> 
 
3.2.3. Proposed structure for Co(II) complex  
As single crystals suitable for X-ray diffraction studies for the Co(II) complex of 
thiosemicarbazone ligand could not be obtained in different solvents, an attempt was conducted 
to determine the composition (metal to ligand ratio) of the complex by using Job’s method [38]. 




fraction of Ligand (VL/(VM + VL)), where VM is the volume of the metal cation solution and VL 
is the volume of the ligand solution. As shown in Fig. 8, the absorption at 370 nm increased as 
the volume fraction of the ligand increased matching the increased formation of the complex. 
The maximum absorbance occurs at ligand volume fraction of around 0.66, suggesting a 
complex of the formula ML2.  
< Fig. 8.> 
In addition, mass spectrometric study of the Co(II) complex with thiosemicarbazone HL have 
been revealed a cation with m/z of 666.3 corresponding to the molecular mass of the structure of 
[CoL2]
+ 
ions (Fig. 9). The mass spectrum of this complex shows a large number of peaks 
assignable to various fragments arising from the thermal cleavage of the complex and ligand 
which suggest that the stoichiometry of the metal to ligand ratio to be 1:2 in the product. A 
schematic representation including the main fragmentation process for Co(II) complex is also 
given in Fig. 9.  
< Fig. 9.> 
In addition, on the basis of IR spectra, the deprotonated thiosemicarbazone ligands are bound to 
cobalt ion in a tridentate binding mode via the pyridine, sulfur and hydrazinic N donor atoms. 
Therefore, Co complex is expected to have a similar structure to that of complex [ZnL2].CH3CN. 
In addition, the similarity of UV–vis spectra between these two complexes suggests a distorted 
octahedral environment. 
 
3.3. Synthesis and characterization of Zn, Co and Ni nano-sized metal oxides 
In this work, the prepared thiosemicarbazone complexes have been used as precursors for the 




are characterized by different spectroscopic methods. The typical powder XRD diffractograms of 
prepared metal oxides are given in Fig. 10. The observed XRD pattern for ZnO nanoparticles 
exhibited several well-defined diffraction peaks which are well-matched with the wurtzite 
hexagonal phase of pure ZnO [39]. All the diffraction peaks agreed with the reported 26170-
ICSD standard data. The XRD result for NiO nanoparticles showed that the prepared solid is 
actually pure nickel oxide [40]. As can be seen, the XRD peaks positions are well matched with 
the reported 92131-ICSD standard data. The XRD results for Co3O4 evidenced that the particles 
obtained were nanocrystalline and had a spinel structure [41]. All the Bragg peaks are consistent 
with those of the reported 56123-ICSD standard data. The average crystallite sizes were 
determined from the peak-width at half-height of the (101) peak for ZnO, the (200) peak for NiO 
and the (311) peak for Co3O4 using the Debye-Scherrer equation: D=kλ/βcosθ, where, D is the 
average crystalline size, k the Scherrer constant (0.89), λ the X-ray wavelength used, β the 
angular line width of half maximum intensity and θ is the Bragg’s angle in degrees unit [42]. The 
calculated average crystallite sizes were found to be 41.6, 29.8 and 21.8 nm for ZnO, NiO, and 
Co3O4, respectively.  
< Fig. 10. > 
The morphologies of the nano metal oxides were determined by scanning electron microscope 
(SEM). The SEM images (Fig. 11) show that the obtained nanoparticles have similar 
morphologies and exhibit an approximately spherical shape. Moreover, the nanoparticles are of 
nano-dimensions in the size distributions ranged from of 20 nm to 40 nm which are consistent 
with the XRD analysis. Energy dispersive X-Ray (EDX) analyses of the synthesized metal 
oxides are presented in Fig. 11, which clearly demonstrated the presence of Zn, Ni and Co in the 




< Fig. 11. > 
The FT‒IR spectra of the oxides are shown in Fig. 12 which confirms the formation of nano-
sized metal oxides via decomposition of thiosemicarbazon complexes. The spectra show 
absorption bands in the 470 – 700 cm
‒1
 regions which assigned to the stretching vibration of the 
M-O bonds. The typical FT-IR measurements for Co3O4 nanoparticles exhibit two absorption 
peaks at 595 cm
‒1
 and 677 cm
‒1
 which assigned to the stretching frequency of the metal–oxygen 
bonds in spinel compounds, respectively [43]. Strong bands around 3500 and 1560 cm
−1
 
appeared in FT–IR spectra of the nanoparticles are attributed to the vibrational modes of O−H 
stretching and bending vibrations of surface hydroxyl groups and physisorbed water molecules. 
In the FT‒IR spectra, all bands that were assigned to functional groups of the thiosemicarbazon 
complexes have been eliminated thus confirming the formation of the proposed pure and single 
phase of metal oxides. 
<Fig.12> 
 
3.4. Antimicrobial Activity 
The newly synthesized thiosemicarbazon complexes and their corresponding nano‒metal oxides 
were tested for their in vitro antibacterial activity against a series of gram positive and gram 
negative bacteria including Micrococcus luteus (M. luteus), Staphylococcus aureus (S. aureus), 
Basillud subtilis (B. subtilis), Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. 
aeruginosa), using the agar disc diffusion method. The antibacterial activity of tested agents was 
monitored at a concentration of 1000 μg/mL in DMSO and the experiments were performed in 
triplicate. The trend in antimicrobial activity of the synthesized compounds was determined by 




mean ± standard deviation in Table 6. Tetracycline and penicillin G were used as positive 
controls. 
The comparison of the experimental results indicated that the complexation of 
thiosemicarbazone ligand affected its antimicrobial properties. Among the thiosemicarbazon 
complexes investigated in this work, [NiLCl] complex possessed a higher inhibition zone against 
S. aureus in comparison with its free ligand [27]. This finding confirmed that the antibacterial 
activity of thiosemicarbazone ligands can be enhanced by the metal center of the coordination 
compound [44]. However, [CoL2] complex was almost less active than HL against tested 
microorganisms, which is consistent with the previously reported cobalt cases [45]. In contrast to 
many reported Zn(II) complexes [46, 47], [ZnL2].CH3CN indicated lower antibacterial activity 
upon complexation with thiosemicarbazon ligand. However, this observation is similar to that of 
previously reported results for zinc(II) complexes with 4-et-hyl-6-{(E)-1-[(3-
nitrophenyl)imino]ethyl}benzene-1,3-diol and 4-eth-yl-6-{(E)-1-[(2-
nitrophenyl)imino]ethyl}benzene-1,3-diol Schiff-base ligands as presented by Nair et al. [48]. 
Bhaskar and coworkers showed that the complexes containing chloride ligand in their structure, 
possessed higher antibacterial activity [49]. Such results were also reported by Ruso et al. [50]. 
Therefore, in the light of the present observation, the higher antibacterial activity of [NiLCl] 
complex compared with [ZnL2].CH3CN and [CoL2] complexes may be attributed to the presence 
of chloride ligand in coordination sphere. This process may be either due to the lipophilic nature 
of the [NiLCl] complex, which favors their effective penetration through the lipid layer of the 
bacterial membrane cell [51]. On the contrary, the lower activity of the Co(II), and Zn(II) 




microorganism membrane and thereby blocking their biological activity or they may diffuse and 
inactivated by unknown cellular mechanism such as bacterial enzymes [52, 53].  
As shown in Table 6, [CoL2] and [NiLCl] complexes showed considerable inhibitory activity 
against the Gram-positive microorganisms tested and also E. coli. The cobalt oxide and zinc 
oxide nanoparticles effectively inhibited all tested aerobic Gram-positive strains and showed 
potential activity against Gram negative E. coli strain. Additionally, zones of bacterial growth 
inhibition of [NiLCl] complex and Co3O4 was greater compared with other synthesized 
compounds in this study. All the compounds have no effect on Gram-negative bacteria, P. 
aeruginosa whereas they are moderately active for E. coli and Gram-positive strains. The activity 
of the Co3O4 and ZnO were in the same range of the penicillin G against the B. subtilis and E. 
coli. The results indicate that the antimicrobial activity of nano-metal oxides is greater than that 
of their corresponding thiosemicarbazon complexes. Such increased activity of the metal oxides 
can be explained by the larger surface to volume ratio of nano-sized particles which results a 
more efficient antibacterial activities. Similar trends were reported previously [54]. 
<Table 6> 
4. Conclusions 
Three new complexes of Zn(II), Ni(II) and Co(II) containing tridentate NNS-donor 
thiosemicarbazone have been prepared using ultrasonic irradiations and structurally 
characterized. The cobalt oxide, nickel oxide and zinc oxide nanoparticles were obtained by 
thermal decomposition of their respective thiosemicarbazone complex precursors at 500 ºC. This 
method yields sphere-like metal oxide nanoparticles with weak agglomeration. The powder XRD 
patterns and EDX images of metal oxides indicate that pure and crystalline metal oxide phases 




by SEM and FT–IR spectroscopy. All these compounds were further tested for antimicrobial 
activity against a series of gram positive and gram negative bacteria, using the zone inhibition 
methods and it was observed that the [NiLCl] complex was shown to possess more antimicrobial 
activity than its nano-sized metal oxide; however the prepared nano-sized zinc and cobalt oxides 
have been found to have the highest activity. The results of antimicrobial properties of 
thiosemicarbazone complexes and the nano-sized metal oxides presented in this study could be 
worthwhile to investigate the structure-bioactivity relationship of such compounds and elucidate 
the specific mechanisms involved in the antimicrobial action. 
 
5. Supplementary material 
The CIF files for crystal structure of [NiLCl]  and [ZnL2]CH3CN complexes have been deposited 
with the CCDC No. 1587531 and 1587532, respectively. These data can be obtained free of 
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Table 1. Crystallographic and structure refinement data for [ZnL2].CH3CN and [NiLCl] 
complexes. 
 ZnL2.CH3CN NiLCl 
Empirical formula C30H27Cl2N9S2Zn
 C14H12Cl2N4NiS 
Formula weight (g/mol) 713.99 397.95 
Temperature (K) 296(2) 296(2) 
Wavelength (Å) 0.71073 0.71073 
Crystal system monoclinic monoclinic 
Space group C2/c C2/m 
Crystal size (mm3) 0.080× 0.060×0.040 0.160× 0.040×0.010 
a (Å) 15.3056(3) 15.2299(4) 
b (Å) 19.3414(4) 6.7241(2) 
c (Å) 11.3234(2) 15.5196(4) 
β (°) 111.8808(10) 105.4872(16) 
Volume (Å3) 3110.60(11) 1531.61(7) 
Z 4 4 
Calculated density (g cm-3) 1.525 1.726 
θ Ranges for data collection (°) 1.5 - 30.0 1.5 - 30.0 
F(000) 1464 808 
Absorption coefficient (mm-1) 1.134 1.751 
Index ranges 
-20≤ h ≤ 20 -20≤ h ≤ 20 
-25≤ k ≤ 23 -8≤ k ≤ 7 
-14≤ l ≤ 6 -20≤ l ≤ 20 
Number of Reflections 16167 13056 
Unique data, (Rint) 856, (0.0707) 306, (0.0509) 
Parameters / restrains 202 / 0 133/ 0 
Final R1 / wR2 (obs. data) 0.0476/  0.0834 0.0397/ 0.0620 
Final R1 / wR2 (all data) 0.0921/0.0952 0.0781/0.0720 
Goodness-of-fit on F2 (S) 1.168 1.086 







Table 2. Infrared frequencies of the characteristic bands of the ligand and corresponding Zn(II), 
Ni(II) and Co(II) complexes. 











HL  3231,3294 1584 – 832 
[ZnL2]  3363 1521 1591 781 
[NiLCl]  3339 1536 1601 769 







Table 3. Selected bond distances (Å) and bond angles (º) for [ZnL2].CH3CN complex 
Zn(1) N(3) 2.147(2) x2  Zn(1) N(4) 2.244(2)x2 
Zn(1) S(1) 2.4632(8) x2  S(1) C(7) 1.725(3) 
N(1) C(7) 1.376(3)  N(2) C(7) 1.314(4) 
N(2) N(3) 1.375(3)  N(3) C(8) 1.291(3) 
N(4) C(10) 1.335(3  N(4) C(9) 1.342(3) 
N(3) Zn(1) N(3) 165.05(12)  N(3) Zn(1) N(4) 73.43(8) 
N(3) Zn(1) N(4) 95.23(8)  N(4) Zn(1) N(4) 83.56(12) 
N(3) Zn(1) S(1) 111.59(6)  N(3) Zn(1) S(1)  78.64(6) 
N(4) Zn(1) S(1)  95.67(6)  N(4) Zn(1) S(1) 151.85(6) 
S(1) Zn1 S(1)   97.79(4)  C(7) S(1) Zn(1)  95.56(9) 
C(8) N(3) Zn(1)  120.03(18)  N(2) N(3) Zn1(4)  123.65(17) 
C(10) N(4) Zn(1)  127.1(2)  C(9) N(4) Zn(1)  114.73(17) 







Table 4. Selected bond distances (Å) and bond angles (º) for [NiLCl]. 
Ni(1) N(3) 1.857(3)  Ni(1) N(4) 1.920(3) 
Ni(1) S(1) 2.1548(11)  Ni(1) Cl(2) 2.1685(12) 
S(1) C(7) 1.751(4)  N(1) C(7) 1.356(5) 
N(1) C(1) 1.410(4)  N(2) C(7) 1.308(4) 
N(2) N(3) 1.381(4)  N(3) C(8) 1.304(4) 
N(4) C(10) 1.335(5)  N(4) C(9) 1.365(4) 
N(3) Ni(1) N(4) 83.27(13)  N(3) Ni(1) S(1)  86.50(10) 
N(4) Ni(1) S(1)  169.77(11)  N(3) Ni(1) Cl(2) 179.42(10) 
N(4) Ni(1) Cl(2) 97.32(10)  S(1) Ni1 Cl(2)   92.92(4) 
C(7) S(1) Ni(1)  95.24(13)  C(8) N(3) Ni(1)  117.8(3) 
N(2) N(3) Ni(1)  124.5(2)  C(9) N(4) Ni(1) 112.5(3) 
C(10) N(4) Ni(1)  128.8(3)  C(7) N(2) N(3) 110.1(3) 














 α β γ 
Cg(1)···Cg(3)
i
 3.682(2) -3.2358(13) -3.3258(15) 3.82(16) 25.4 28.5 
Cg(1)···Cg(3)
ii
 3.542 (2) 3.4973(13) 3.4591(15) 3.82(16) 12.5 9.1 
Cg(2)···Cg(3)
i
 3.542 (2) 3.4591(15) 3.4974(13) 3.82(16) 9.1 12.5 
Cg(2)···Cg(3)
ii
 3.682(2) -3.3258(15) -3.2357(13) 3.82(16) 28.5 25.4 
Cg(3)···Cg(1)
i
 3.877(2) 3.4774(15) 3.4186(19) 4.1(2) 28.2 26.3 
Cg(3)···Cg(2)
i
 3.878(2) 3.4187(19) 3.4774(15) 4.1(2) 26.3 28.2 
Cg(3)···Cg(1)
ii
 3.878(2) 3.4187(19) 3.4774(15) 4.1(2) 26.3 28.2 
Cg(3)···Cg(2)
ii
 3.878(2) 3.4187(19) 3.4774(15) 4.1(2) 26.3 28.2 
Symmetry codes: (iii) = -4+x, 5/2-y, 1/2+z; (iv) = -3+x, 5/2-y, 1/2+z.  
a Distance between the centroids of ring i and ring j.  
b Perpendicular distance from the centroid of ring i to ring j.  
c Perpendicular distance from the centroid of ring j to ring i.  
α = Dihedral angle between ring i and ring j(°); β = angle Cg(i)–Cg(j) vector and normal to plane i (°); γ=  ngle Cg(i)–Cg(j) vector 








Table 6. Antibacterial activity of synthesized compounds and comparison to penicillin G and 
tetracycline as zone of inhibition (mm).  
compounds 
 Antibacterial activity (mean±SD) 
Gram Positive Bacteria  Gram Negative Bacteria 
M. luteus S. aureus B. subtilis E. coli P. aeruginosa 
HL* 20±1 12±1.0 15 ±1 12±1 10±1 
[CoL2] 8 ±1 10 ±1 10 ± 1  8 ± 1 - 
[NiLCl] 16 ±1  17± 1 9 ±1  7 ± 1 - 
[ZnL2]CH3CN - - 6 ±1  - - 
Co3O4 11±1 - 15±1  16± 1 - 
NiO - - 15± 1  12±1 - 
ZnO 14 ± 1 8 ± 1 10±1  14± 1 - 
Penicillin G 50± 1 50±1 15± 1  18± 1 - 
Tetracycline 46± 1 41± 1 31± 1  31± 1 27± 1 












 Three new Zn(II), Co(II) and Ni(II) thiosemicarbazone complexes have been prepared 
using ultrasonic irradiations. 
 Crystal structures and spectroscopic methods revealed distorted octahedral and/or square-
planar coordination geometry around the central metals. 
 The direct thermolysis of thiosemicarbazone complexes led to nano-sized metal oxides. 






Fig. 1. FT–IR spectra of HL, [ZnL2].CH3CN, [CoL2] and [NiLCl] compounds. 
 
  
























Fig. 2. The 
1
H NMR spectra of (a) NiLCl and (b) ZnL2 complexes. The insets show the 




































Fig. 4. Molecular structure of [ZnL2].CH3CN complex, showing the atom‒labelling system and 







Fig. 5. Capped-stick representation of the packing of [ZnL2].CH3CN complex showing N–H⋯S 
























Fig. 8. Job’s plot based on UV– is studies (at λ=370 nm) for the prepared Co(II) complex in 





























Fig. 9. Mass spectrum of the Co(II) complex. The inset shows the mass fragmentation routes of 








Fig. 10. XRD patterns of ZnO, NiO and Co3O4 nanoparticles obtained by thermal decomposition. 
Standard XRD patterns are also presented for comparison. 
 
























































































































Fig. 12. The FT‒IR spectra of the nano-metal oxides. 
 
 
